Status:

COMPLETED

Effect of the Antioxidant Micronutrients of Rapeseed Oil on the Prevention of Cardiovascular Diseases (Optim'Oils)

Lead Sponsor:

University Hospital, Clermont-Ferrand

Collaborating Sponsors:

Centre de Recherche en Nutrition Humaine d'Auvergne

Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement

Conditions:

Cardiovascular Diseases

Eligibility:

MALE

30-65 years

Phase:

NA

Brief Summary

The purpose of this study is to assess the effect of optimized oil (enriched with micronutriments) on the prevention on cardiovascular diseases. Randomised crossover dietary intervention study: The ...

Detailed Description

For both studies, sedentary men between 30 and 65 years of age, with a BMI between 25 and 30, without cardiovascular disorders, will be selected. Randomised crossover dietary intervention study: Six...

Eligibility Criteria

Inclusion

  • Male
  • Age : 30 to 65
  • Body mass index between 25 and 30 kg/m²
  • Weight lower than 110 kg
  • Subject considered as normal after clinical examination and medical questionnaire
  • Subject giving his written informed consent
  • Subject willing to comply with the study procedures
  • Affiliated to National Health Insurance

Exclusion

  • Biological results judged abnormal by investigator
  • Positive serologies to HIV or HCV
  • Previous medical and/or surgery judged by the investigator as incompatible with the study
  • Taking medicine: hypocholesterolemic,beta blockers, IEC,
  • Diabetes1 and 2
  • High blood pressure
  • Digestive, cardiovascular, renal, liver, tumor or thyroid diseases in the last 5 years
  • Infectious or inflammatory diseases in the last 5 years
  • Previous heavy intestine surgery (except appendectomy)
  • Triglycerides\> 4 g/L
  • Dyslipidemia: HDL cholesterol\< 0.4 g/L or LDL/HDL\>6.25
  • blood donation done less than 2 month before the start of the study
  • Particular diet: vegetarian, vegan...
  • Anormal dietary habits
  • Consumption of food complements: antioxidant, ...
  • intense physical exercise practise (\>5 h per week)
  • Tobacco, alcohol:more than 30 g of alcohol/day, i.e.3 glasses/day, smoking \> 5 cigarettes /day
  • No affiliated to National Health Insurance people
  • Refusal to sign informed consent
  • Refusal to be registered on the National Volunteers Data file
  • Currently participating or who having got 4500 E in this year before to have participated in another clinical trial

Key Trial Info

Start Date :

December 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2009

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT00852735

Start Date

December 1 2008

End Date

July 1 2009

Last Update

March 10 2010

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CRNH Auvergne

Clermont-Ferrand, France, 63000